Dr. Nafziger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 High Park Ave
Goshen, IN 46526Phone+1 574-364-2865
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Infectious Disease, 1990 - 1993
- University of IowaMS, Preventive Medicine and Environmental Health (Epidemiology), 1993
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1987 - 1990
- Case Western Reserve University School of MedicineClass of 1987
- Eastern Mennonite UniversityBS, Summa Cum Laude, 1983
Certifications & Licensure
- IN State Medical License 2002 - 2025
- MI State Medical License 1993 - 2018
- IA State Medical License 1987 - 1994
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Professional Achievement Award Goshen General Hospital, 2003
- Ohio Department of Aging, Geriatric Medicine Award 1987
- National Merit Finalist 1979
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsDifferentiating Inhalational Anthrax From Other Influenzalike Illnesses in the Setting of a National or Regional Anthrax OutbreakSandro Cinti, Louis D. Saravolatz, Daniel Nafziger, James Sunstrum, Gerald Blackburn
Archives of Internal Medicine. 2004-03-22 - 22 citationsLinezolid for treatment of vancomycin-resistant enterococcal peritonitis.Elaine M. Bailey, Mark D. Faber, Daniel A. Nafziger
American Journal of Kidney Diseases. 2001-10-01 - 17 citationsStaphylococcus epidermidis with Intermediate Resistance to Vancomycin: Elusive Phenotype or Laboratory Artifact?William Michael Dunne, Hina S. Qureshi, Hassan Pervez, Daniel A. Nafziger
Clinical Infectious Diseases. 2001-07-01
Journal Articles
- Differentiating inhalational anthrax from other influenza-like illnesses in the setting of a national or regional anthrax outbreakCinti SK, Saravolatz L, Nafziger D, Sunstrum J, Blackburn G, Arch Intern Med, 1/1/2004
- Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine unitsKucukarslan SN, Peters M, Mylnarek M, Nafziger DA, Arch Intern Med, 1/1/2003
- Phase I Study of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy for the Treatment of Locally Recurrent Prostate CancerFreytag, SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E, Kim JH, Cancer Research, 1/1/2002
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Autism and vaccines? Let’s think againHershberger J, Nafziger DA, Snyder JK, The Mennonite, 10/1/2012
- Evaluation of a Silver Hydrogel Urinary Catheter for the Prevention of Nosocomial Urinary Tract InfectionsNafziger D, Jandourek A, 39th Annual Meeting of the Infectious Disease Society of America, 1/1/2001
- Successful Chlorination for Legionella at Henry Ford HospitalNafziger DA, Infect Dis Clin Pract, 1/1/1998
- Join now to see all
Lectures
- Death Certification4/16/2014
- Antimicrobial Resistance3/18/2014
- Bad Bugs, No Drugs: Indiana Style- Medical Staff Education3/18/2014
- Join now to see all
Press Mentions
- Northern Indiana Counties Hit with Widespread COVIDDecember 9th, 2021
- County Council Won't Allow Grant Application for Health EducatorsSeptember 11th, 2021
- Jason Lippert Among Local Leaders Urging VaccinationsMay 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: